Risk-taking and pathological gambling behavior in Huntington's disease.

Carla Kalkhoven, Cor Sennef, Ard Peeters, Ruud van den Bos
Author Information
  1. Carla Kalkhoven: Chardon Pharma, Herpen Netherlands.
  2. Cor Sennef: Chardon Pharma, Herpen Netherlands.
  3. Ard Peeters: Chardon Pharma, Herpen Netherlands.
  4. Ruud van den Bos: Department of Organismal Animal Physiology, Faculty of Science, Radboud University Nijmegen Nijmegen, Netherlands.

Abstract

Huntington's disease (HD) is a genetic, neurodegenerative disorder, which specifically affects striatal neurons of the indirect pathway, resulting in a progressive decline in muscle coordination and loss of emotional and cognitive control. Interestingly, predisposition to pathological gambling and other addictions involves disturbances in the same cortico-striatal circuits that are affected in HD, and display similar disinhibition-related symptoms, including changed sensitivity to punishments and rewards, impulsivity, and inability to consider long-term advantages over short-term rewards. Both HD patients and pathological gamblers also show similar performance deficits on risky decision-making tasks, such as the Iowa Gambling Task (IGT). These similarities suggest that HD patients are a likely risk group for gambling problems. However, such problems have only incidentally been observed in HD patients. In this review, we aim to characterize the risk of pathological gambling in HD, as well as the underlying neurobiological mechanisms. Especially with the current rise of easily accessible Internet gambling opportunities, it is important to understand these risks and provide appropriate patient support accordingly. Based on neuropathological and behavioral findings, we propose that HD patients may not have an increased tendency to seek risks and start gambling, but that they do have an increased chance of developing an addiction once they engage in gambling activities. Therefore, current and future developments of Internet gambling possibilities and related addictions should be regarded with care, especially for vulnerable groups like HD patients.

Keywords

References

  1. Front Psychol. 2014 Mar 18;5:203 [PMID: 24672498]
  2. J Genet Couns. 2007 Jun;16(3):347-62 [PMID: 17473962]
  3. Dialogues Clin Neurosci. 2007;9(2):141-51 [PMID: 17726913]
  4. Neuropsychologia. 2010 Jan;48(2):549-57 [PMID: 19878688]
  5. Trends Neurosci. 1989 Oct;12(10):366-75 [PMID: 2479133]
  6. Biol Psychiatry. 2007 Dec 15;62(12):1341-6 [PMID: 17481592]
  7. Handb Clin Neurol. 2011;100:ix [PMID: 21496566]
  8. J Int Neuropsychol Soc. 2004 Mar;10(2):239-45 [PMID: 15012844]
  9. Neuropsychopharmacology. 2010 Jan;35(1):4-26 [PMID: 19812543]
  10. Nature. 2000 Feb 3;403(6769):544-9 [PMID: 10676962]
  11. Brain. 2002 Aug;125(Pt 8):1815-28 [PMID: 12135972]
  12. Psychiatry Res. 2013 May 15;207(1-2):118-26 [PMID: 23051887]
  13. Neuropsychologia. 2008;46(8):2152-60 [PMID: 18407301]
  14. J Behav Ther Exp Psychiatry. 2011 Sep;42(3):265-9 [PMID: 21349247]
  15. Acta Neuropathol. 2008 Jan;115(1):55-69 [PMID: 17978822]
  16. Int Rev Neurobiol. 2011;98:325-72 [PMID: 21907094]
  17. Psychol Addict Behav. 2011 Dec;25(4):675-82 [PMID: 21688874]
  18. Neurocase. 2004 Oct;10(5):398-403 [PMID: 15788279]
  19. Clin Psychol Rev. 2002 Feb;22(1):1-25 [PMID: 11793575]
  20. Trends Genet. 2004 Mar;20(3):146-54 [PMID: 15036808]
  21. Cyberpsychol Behav. 2003 Dec;6(6):557-68 [PMID: 14756922]
  22. Front Biosci (Schol Ed). 2013 Jan 01;5(1):1-18 [PMID: 23277034]
  23. J Clin Exp Neuropsychol. 2007 May;29(4):365-76 [PMID: 17497560]
  24. Mov Disord. 1999 Jan;14(1):95-101 [PMID: 9918350]
  25. Brain Res Bull. 2012 Jun 1;88(2-3):223-36 [PMID: 21963415]
  26. Behav Brain Res. 2013 Feb 1;238:243-51 [PMID: 23123142]
  27. Brain. 1996 Oct;119 ( Pt 5):1633-45 [PMID: 8931586]
  28. Brain Cogn. 2011 Nov;77(2):280-91 [PMID: 21889251]
  29. J Neurol. 2011 Mar;258(3):412-20 [PMID: 20936300]
  30. Neuropsychol Rev. 2009 Mar;19(1):102-14 [PMID: 19194801]
  31. Neurobiol Learn Mem. 2011 Jan;95(1):92-101 [PMID: 21111837]
  32. Annu Rev Clin Psychol. 2008;4:325-48 [PMID: 18370620]
  33. Psychiatry Res. 2012 Aug-Sep;203(2-3):166-74 [PMID: 22974690]
  34. Brain. 2002 Mar;125(Pt 3):624-39 [PMID: 11872618]
  35. Nat Neurosci. 2012 May 25;15(6):807-9 [PMID: 22627791]
  36. Psychiatry Res. 2005 Jan 30;133(1):91-9 [PMID: 15698681]
  37. Trends Cogn Sci. 2007 Apr;11(4):168-76 [PMID: 17337237]
  38. Nat Neurosci. 2012 Jun;15(6):816-8 [PMID: 22544310]
  39. Psychiatr Dev. 1983 Summer;1(2):193-205 [PMID: 6232607]
  40. Eur J Neurol. 2007 Dec;14(12):1344-50 [PMID: 17941857]
  41. Nat Genet. 1993 Aug;4(4):393-7 [PMID: 8401588]
  42. Neuropsychiatry Neuropsychol Behav Neurol. 2001 Oct-Dec;14(4):219-26 [PMID: 11725215]
  43. J Neurol Neurosurg Psychiatry. 1995 May;58(5):598-606 [PMID: 7745410]
  44. Front Neurosci. 2011 Oct 10;5:109 [PMID: 22013406]
  45. Cereb Cortex. 2005 Jan;15(1):58-63 [PMID: 15217900]
  46. Neurosci Biobehav Rev. 2004 Apr;28(2):123-41 [PMID: 15172761]
  47. Behav Brain Res. 2013 Feb 1;238:95-108 [PMID: 23078950]
  48. J Neurol Neurosurg Psychiatry. 2007 Sep;78(9):939-43 [PMID: 17178819]
  49. Psychiatry Res. 2012 Dec 30;200(2-3):568-74 [PMID: 22521232]
  50. Hum Mol Genet. 1993 Oct;2(10):1547-9 [PMID: 8268907]
  51. Neurology. 2005 Sep 13;65(5):745-7 [PMID: 16157910]
  52. Neurology. 2013 Jan 8;80(2):176-80 [PMID: 23296128]
  53. Arch Neurol. 1997 Nov;54(11):1353-7 [PMID: 9362982]
  54. Neuropsychologia. 1992 Jan;30(1):69-79 [PMID: 1738471]
  55. Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2454-71 [PMID: 23867802]
  56. J Neurol Neurosurg Psychiatry. 2004 Feb;75(2):213-20 [PMID: 14742591]
  57. J Psychiatry Neurosci. 2011 Nov;36(6):383-90 [PMID: 21406159]
  58. Neuropsychopharmacology. 1999 Apr;20(4):322-39 [PMID: 10088133]
  59. Cereb Cortex. 2000 Mar;10(3):295-307 [PMID: 10731224]
  60. Nature. 1996 Mar 7;380(6569):69-72 [PMID: 8598908]
  61. Brain. 2007 Nov;130(Pt 11):2845-57 [PMID: 17855375]
  62. Neuropsychopharmacology. 2010 Jan;35(1):27-47 [PMID: 19675534]
  63. Psychiatry Res. 2008 Jan 15;162(1):73-87 [PMID: 18068955]
  64. Orphanet J Rare Dis. 2010 Dec 20;5:40 [PMID: 21171977]
  65. Behav Pharmacol. 2002 Sep;13(5-6):355-66 [PMID: 12394411]
  66. Mov Disord. 2008 May 15;23(7):970-976 [PMID: 18381643]
  67. Neuropsychology. 2011 Jan;25(1):1-14 [PMID: 20919768]
  68. Trends Neurosci. 1990 Jul;13(7):266-71 [PMID: 1695401]
  69. Arch Neurol. 2005 Sep;62(9):1377-81 [PMID: 16009751]
  70. Dysphagia. 2011 Mar;26(1):62-6 [PMID: 20838817]
  71. Neurodegener Dis. 2014;13(1):9-16 [PMID: 23948661]
  72. Cognition. 1994 Apr-Jun;50(1-3):7-15 [PMID: 8039375]
  73. Arch Neurol. 1999 May;56(5):563-8 [PMID: 10328251]
  74. Science. 1994 Sep 23;265(5180):1826-31 [PMID: 8091209]
  75. Lancet Neurol. 2009 Sep;8(9):791-801 [PMID: 19646924]
  76. Neurology. 2012 Oct 16;79(16):1708-15 [PMID: 23035064]
  77. Arch Neurol. 1988 Jul;45(7):769-73 [PMID: 2968784]
  78. Neurosci Biobehav Rev. 2010 Jan;34(1):87-107 [PMID: 19632269]
  79. J Int Neuropsychol Soc. 2001 Jan;7(1):92-101 [PMID: 11253845]
  80. Behav Brain Res. 2003 Nov 30;146(1-2):97-103 [PMID: 14643463]
  81. Acta Psychiatr Scand. 1998 Jan;97(1):62-5 [PMID: 9504705]
  82. Arch Neurol. 1983 Dec;40(13):791-6 [PMID: 6227312]
  83. Neurology. 1986 Feb;36(2):244-9 [PMID: 2935747]
  84. Nat Rev Neurosci. 2006 Jun;7(6):464-76 [PMID: 16715055]
  85. Neurology. 1968 Mar;18(3):217-24 [PMID: 4231060]
  86. Psychosomatics. 2004 May-Jun;45(3):247-55 [PMID: 15123852]
  87. Hum Brain Mapp. 2013 Jul;34(7):1625-35 [PMID: 22359398]
  88. Curr Opin Neurobiol. 2013 Aug;23(4):660-7 [PMID: 23541597]
  89. Biol Psychiatry. 2012 Apr 15;71(8):741-8 [PMID: 22342105]
  90. Nat Neurosci. 2008 Apr;11(4):410-6 [PMID: 18368048]
  91. Nat Rev Neurol. 2010 Nov;6(11):611-23 [PMID: 21045795]
  92. J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):120-2 [PMID: 12486282]
  93. Rev Neurol (Paris). 2012 Aug-Sep;168(8-9):624-33 [PMID: 22921247]
  94. PLoS One. 2012;7(11):e50647 [PMID: 23209796]
  95. Neuropsychologia. 2000;38(8):1112-25 [PMID: 10838146]
  96. Clin Psychol Rev. 2002 Sep;22(7):1009-61 [PMID: 12238245]
  97. Mov Disord. 2013 Jul;28(8):1104-9 [PMID: 23436289]
  98. Science. 2003 Mar 21;299(5614):1898-902 [PMID: 12649484]
  99. Handb Clin Neurol. 2011;100:3-13 [PMID: 21496568]
  100. Exp Brain Res. 2008 Apr;186(3):457-69 [PMID: 18185924]
  101. J Neuropsychiatry Clin Neurosci. 2010 Spring;22(2):196-207 [PMID: 20463114]
  102. Cell. 1993 Mar 26;72(6):971-83 [PMID: 8458085]
  103. Nat Neurosci. 2001 Jan;4(1):95-102 [PMID: 11135651]
  104. Ann Otol Rhinol Laryngol. 1986 May-Jun;95(3 Pt 1):288-93 [PMID: 2940956]
  105. Dialogues Clin Neurosci. 2007;9(2):191-7 [PMID: 17726917]
  106. J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):874-80 [PMID: 18096682]
  107. Arch Neurol. 2001 Feb;58(2):273-8 [PMID: 11176966]
  108. J Neuropathol Exp Neurol. 1998 May;57(5):369-84 [PMID: 9596408]
  109. Curr Opin Pharmacol. 2007 Feb;7(1):69-76 [PMID: 17174602]
  110. Neurology. 1992 Jun;42(6):1232-8 [PMID: 1534875]
  111. Neurology. 2010 Aug 10;75(6):500-7 [PMID: 20610833]
  112. J Psychiatr Res. 2013 Oct;47(10):1423-31 [PMID: 23790259]
  113. Am J Psychiatry. 1983 Jun;140(6):728-33 [PMID: 6221669]
  114. Handb Clin Neurol. 2011;100:83-100 [PMID: 21496571]
  115. Acta Psychiatr Scand. 1994 Oct;90(4):241-6 [PMID: 7831992]
  116. J Psychosom Res. 2002 Aug;53(2):647-54 [PMID: 12169339]
  117. Brain. 2007 Jul;130(Pt 7):1732-44 [PMID: 17584778]
  118. Biol Psychiatry. 2002 Feb 15;51(4):334-41 [PMID: 11958785]
  119. Eur J Neurosci. 2008 Oct;28(8):1437-48 [PMID: 18793321]
  120. Neurology. 1985 Oct;35(10):1450-4 [PMID: 3162109]
  121. J Neurol Neurosurg Psychiatry. 1998 Feb;64(2):172-7 [PMID: 9489526]
  122. J Med Genet. 1995 May;32(5):358-62 [PMID: 7616542]
  123. Behav Neurosci. 2012 Jun;126(3):479-87 [PMID: 22642889]
  124. Arch Neurol. 1995 Jan;52(1):59-64 [PMID: 7826277]
  125. Ann Neurol. 1995 May;37(5):657-64 [PMID: 7755361]
  126. J Neuropsychiatry Clin Neurosci. 2007 Fall;19(4):441-8 [PMID: 18070848]
  127. Front Psychol. 2013 Sep 30;4:665 [PMID: 24137138]
  128. Annu Rev Neurosci. 1986;9:357-81 [PMID: 3085570]
  129. Arch Neurol. 1962 Oct;7:275-88 [PMID: 13971267]
  130. Psychol Assess. 2002 Sep;14(3):253-62 [PMID: 12214432]
  131. Prog Brain Res. 1990;85:119-46 [PMID: 2094891]
  132. Int Rev Neurobiol. 2011;98:373-418 [PMID: 21907095]
  133. J Nerv Ment Dis. 1993 Mar;181(3):194-9 [PMID: 8445379]

Word Cloud

Created with Highcharts 10.0.0gamblingHDpatientspathologicaldiseaseHuntington'saddictionssimilarrewardsriskproblemscurrentInternetrisksincreasedgeneticneurodegenerativedisorderspecificallyaffectsstriatalneuronsindirectpathwayresultingprogressivedeclinemusclecoordinationlossemotionalcognitivecontrolInterestinglypredispositioninvolvesdisturbancescortico-striatalcircuitsaffecteddisplaydisinhibition-relatedsymptomsincludingchangedsensitivitypunishmentsimpulsivityinabilityconsiderlong-termadvantagesshort-termgamblersalsoshowperformancedeficitsriskydecision-makingtasksIowaGamblingTaskIGTsimilaritiessuggestlikelygroupHoweverincidentallyobservedreviewaimcharacterizewellunderlyingneurobiologicalmechanismsEspeciallyriseeasilyaccessibleopportunitiesimportantunderstandprovideappropriatepatientsupportaccordinglyBasedneuropathologicalbehavioralfindingsproposemaytendencyseekstartchancedevelopingaddictionengageactivitiesThereforefuturedevelopmentspossibilitiesrelatedregardedcareespeciallyvulnerablegroupslikeRisk-takingbehaviorHuntington’sbasalgangliadisinhibtionprefrontalcortexrisk-taking

Similar Articles

Cited By (13)